✦ LIBER ✦

Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial

✍ Scribed by Thanyawee Puthanakit; Vonthanak Saphonn; Jintanat Ananworanich; Pope Kosalaraksa; Rawiwan Hansudewechakul; Ung Vibol; Stephen J Kerr; Suparat Kanjanavanit; Chaiwat Ngampiyaskul; Jurai Wongsawat; Wicharn Luesomboon; Nicole Ngo-Giang-Huong; Kea Chettra; Theshinee Cheunyam; Tulathip Suwarnlerk; Sasiwimol Ubolyam; William T Shearer; Robert Paul; Lynne M Mofenson; Lawrence Fox; Matthew G Law; David A Cooper; Praphan Phanuphak; Mean Chhi Vun; Kiat Ruxrungtham

Book ID: 119613007
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 259 KB
Volume: 12
Category: Article
ISSN: 1473-3099
DOI: 10.1016/s1473-3099(12)70242-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early time-limited antiretroviral therap

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

✍ Cotton, Mark F; Violari, Avy; Otwombe, Kennedy; Panchia, Ravindre; Dobbels, Els; 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 293 KB

Routine versus clinically driven laborat

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial

📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 438 KB

First-line antiretroviral therapy with a

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial

📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 276 KB